AD/PD
1-5 April, 2025 // Vienna, Austria
Join Worldwide Clinical Trials at the AD/PD Conference.
0
days leftAbout event
Our experienced Alzheimer’s and Dementia team will make it clear why our clients come back again and again. Our project managers, physicians, statisticians, supply chain managers, central laboratory techs, and operations experts keep a laser focus on the holistic goal—improved patient health—from start to finish. If you are attending AD/PD, please reach out and schedule a meeting with our team to learn more about Worldwide’s extensive capabilities.
Dr. Babic will be presenting “Biomarker Utilization in CNS Alpha-Synuclein Related Disorders (CNS-ASRD) Treatment Trials” on 1 April at 1:15pm CES.
He will also be participating in the forum: “Novel approaches to accelerate development of Biomarkers, Imaging, and Therapy of Apha-Synuclein, LRKK2 and GBA Pathologies linked to PD, LBD, and MSA” on 4 April at 4:20pm CES.
Date
Tuesday to Saturday
1-5 April, 2025
Venue
Austria Center Vienna
Bruno-Kreisky-Platz 1, 1220 Wien, Austria
Tom Babic
Vice President, Scientific Solutions, Neuroscience
Tom Babic, MD, PhD, Vice President of the Neuroscience Franchise at Worldwide Clinical Trials, is a therapeutic leader in neurology medical and scientific affairs, with experience in both industry and academia. Currently, Dr. Babic provides scientific and medical leadership for global neurology clinical research initiatives. He is involved in hypothesis generation and testing, protocol design and development, and clinical analysis of results for all phases of clinical drug development.
